• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者发生心脏损伤的危险因素:肺通气功能障碍和氧吸入不足不是直接原因。

Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes.

机构信息

Emergency Department, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China.

Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China.

出版信息

Aging (Albany NY). 2020 Nov 23;12(23):23464-23477. doi: 10.18632/aging.104148.

DOI:10.18632/aging.104148
PMID:33226958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762512/
Abstract

BACKGROUND

Cardiac injury in patients with coronavirus disease 2019 (COVID-19) has been reported in recent studies. However, reports on the risk factors for cardiac injury and their prognostic value are limited.

RESULTS

In total, 15.9% of all cases were defined as cardiac injury in our study. Patients with severe COVID-19 were significantly associated with older age and higher respiratory rates, Sequential Organ Failure Assessment (SOFA) scores, cardiac injury biomarkers and PaO/FiO ratios. Male patients with chest distress and dyspnea were more likely to have severe disease. Patients with cardiac injury were significantly more likely to have a severe condition and have an outcome of death. However, no significant difference was found in respiratory rates, dyspnea or PaO/FiO ratio between patients with or without cardiac injury. In the logistic regression model, pre-existing hypertension and higher SOFA score were independent risk factors for patients with COVID-19 developing cardiac injury.

CONCLUSIONS

Our study revealed that cardiac injury was an important predictor for patients having a severe or fatal outcome. Patients with pre-existing hypertension and higher SOFA scores upon admission were more likely to develop cardiac injury. Nevertheless, pulmonary ventilation dysfunction and oxygen inhalation insufficiency were not the main causes of cardiac injury in patients with COVID-19.

METHODS

A total of 113 confirmed cases were included in our study. Severe patients were defined according to American Thoracic Society guidelines for community-acquired pneumonia. Cardiac injury was defined as a serum cTnI above the 99-percentile of the upper reference limit. Patient characteristics, clinical laboratory data and treatment details were collected and analyzed. The risk factors for patients with and without cardiac injury were analyzed.

摘要

背景

最近的研究报告称,2019 年冠状病毒病(COVID-19)患者存在心脏损伤。然而,关于心脏损伤的危险因素及其预后价值的报告有限。

结果

在我们的研究中,共有 15.9%的病例被定义为心脏损伤。患有严重 COVID-19 的患者与年龄较大、呼吸频率较高、序贯器官衰竭评估(SOFA)评分、心脏损伤生物标志物和 PaO/FiO 比值较高显著相关。有胸部不适和呼吸困难的男性患者更有可能患有严重疾病。有心脏损伤的患者更有可能出现严重情况,并导致死亡。然而,在有或没有心脏损伤的患者之间,呼吸频率、呼吸困难或 PaO/FiO 比值没有差异。在逻辑回归模型中,高血压和 SOFA 评分较高是 COVID-19 患者发生心脏损伤的独立危险因素。

结论

我们的研究表明,心脏损伤是患者出现严重或致命结局的重要预测因素。患有高血压和入院时 SOFA 评分较高的患者更有可能发生心脏损伤。然而,肺通气功能障碍和氧吸入不足不是 COVID-19 患者心脏损伤的主要原因。

方法

我们的研究共纳入了 113 例确诊病例。严重患者根据美国胸科学会社区获得性肺炎指南定义。心脏损伤定义为血清 cTnI 高于 99%参考上限。收集和分析了患者特征、临床实验室数据和治疗细节。分析了有和没有心脏损伤的患者的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/2849dfc142c3/aging-12-104148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/0a237edd0456/aging-12-104148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/2ac42d9c3fb7/aging-12-104148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/2849dfc142c3/aging-12-104148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/0a237edd0456/aging-12-104148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/2ac42d9c3fb7/aging-12-104148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197f/7762512/2849dfc142c3/aging-12-104148-g003.jpg

相似文献

1
Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes.COVID-19 患者发生心脏损伤的危险因素:肺通气功能障碍和氧吸入不足不是直接原因。
Aging (Albany NY). 2020 Nov 23;12(23):23464-23477. doi: 10.18632/aging.104148.
2
Cardiac manifestations of COVID-19 in Shenzhen, China.中国深圳的 COVID-19 的心脏表现。
Infection. 2020 Dec;48(6):861-870. doi: 10.1007/s15010-020-01473-w. Epub 2020 Jul 28.
3
Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19).新冠肺炎(COVID-19)重型患者的心脏损伤。
BMC Cardiovasc Disord. 2020 Nov 10;20(1):479. doi: 10.1186/s12872-020-01758-w.
4
Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease.新冠肺炎合并和不合并冠状动脉疾病患者的心脏损伤的预后意义。
Coron Artery Dis. 2021 Aug 1;32(5):359-366. doi: 10.1097/MCA.0000000000000914.
5
The value of clinical parameters in predicting the severity of COVID-19.临床参数在预测 COVID-19 严重程度中的价值。
J Med Virol. 2020 Oct;92(10):2188-2192. doi: 10.1002/jmv.26031. Epub 2020 Jun 2.
6
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.
7
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
8
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
9
[Risk factors analysis of acute respiratory distress syndrome in intensive care unit traumatic patients].[重症监护病房创伤患者急性呼吸窘迫综合征的危险因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Oct;30(10):978-982. doi: 10.3760/cma.j.issn.2095-4352.2018.010.015.
10
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.在住院的 COVID-19 患者中,心脏损伤、炎症和凝血生物标志物与结局的纵向相关性。
J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.

引用本文的文献

1
Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients.新型冠状病毒肺炎中的亚临床心肌损伤、凝血病和炎症:对41013例住院患者的荟萃分析
Int J Cardiol Heart Vasc. 2022 Jun;40:100950. doi: 10.1016/j.ijcha.2021.100950. Epub 2022 Jan 4.
2
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.2019冠状病毒病,世纪大流行及其对心血管疾病的影响。
Cardiol Discov. 2021 Nov 22;1(4):233-258. doi: 10.1097/CD9.0000000000000038. eCollection 2021 Dec.
3
Predictive Significance of the Prognostic Nutritional Index (PNI) in Patients with Severe COVID-19.

本文引用的文献

1
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.肾素-血管紧张素系统(RAS)阻滞剂对高血压COVID-19患者临床特征的影响。
Ann Transl Med. 2020 Apr;8(7):430. doi: 10.21037/atm.2020.03.229.
2
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
3
Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
预后营养指数(PNI)对重症 COVID-19 患者的预测意义。
J Immunol Res. 2021 Jul 9;2021:9917302. doi: 10.1155/2021/9917302. eCollection 2021.
4
Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients.COVID-19 住院患者心血管事件的结局和危险因素。
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3581-3593. doi: 10.1053/j.jvca.2021.03.035. Epub 2021 Mar 27.
对《基于对来自中国武汉的150例患者数据的分析的2019冠状病毒病死亡的临床预测因素》的更正
Intensive Care Med. 2020 Jun;46(6):1294-1297. doi: 10.1007/s00134-020-06028-z.
4
COVID-19 and the Heart.新型冠状病毒肺炎与心脏
Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.
5
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).新型冠状病毒病 2019(COVID-19)的流行病学、诊断、治疗和疫苗的现状。
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011.
6
Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.分析中国武汉一家医院 273 例 COVID-19 患者的心脏损伤实验室参数。
J Med Virol. 2020 Jul;92(7):819-823. doi: 10.1002/jmv.25809. Epub 2020 Apr 15.
7
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
8
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究:中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎(COVID-19)的风险会增加吗?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.